Janney Montgomery Scott
RANI icon

Janney Montgomery Scott’s Rani Therapeutics RANI Stock Holding History

Janney Montgomery Scott’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37K Hold
49,200
– – ﹤0.01% 3095
2026
Q1 		$36K Hold
49,200
– – ﹤0.01% 2728
2025
Q4 		$66K Hold
49,200
– – ﹤0.01% 2885
2025
Q3 		$25K Sell
49,200
-6,000
-11% -$3.13K ﹤0.01% 2842
2025
Q2 		$28K Buy
55,200
+28,000
+103% +$22.8K ﹤0.01% 2683
2025
Q1 		$34K Hold
27,200
– – ﹤0.01% 2645
2024
Q4 		$37K Buy
+27,200
New +$57.2K ﹤0.01% 2665

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Janney Montgomery Scott's RANI Position: Q2 2026 in Review

Janney Montgomery Scott held its Rani Therapeutics (RANI) position steady in Q2 2026 at 49,200 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Janney Montgomery Scott first reported a position in RANI in Q4 2024 and has held it in 7 quarters since. The position peaked at $66K in Q4 2025. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Janney Montgomery Scott held 49,200 shares of Rani Therapeutics worth $37K as of Q2 2026.
  • Janney Montgomery Scott left its Rani Therapeutics share count unchanged in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3095 holding.
  • Janney Montgomery Scott first reported a position in Rani Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Janney Montgomery Scott's Rani Therapeutics position peaked at $66K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.